ECAS correlation with metabolic alterations on FDG-PET imaging in ALS

References

• del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813–9. PMID: 12629239.
   PubMed Web of Science ®Google Scholar
• Katz JS, Katzberg HD, Woolley SC, Marklund SL, Andersen PM. Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation. Amyotroph Lateral Scler. 2012;13:567–9.
   PubMed Web of Science ®Google Scholar
• Ng ASL, Rademakers R, Miller BL. Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann N Y Acad Sci. 2015;1338:71–93.
   PubMed Web of Science ®Google Scholar
• van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084–98.
   PubMed Web of Science ®Google Scholar
• Chì A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93(10):e984–e994.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
   PubMed Web of Science ®Google Scholar
• Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, de Haan RJ. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016;87:611–9.
   PubMed Web of Science ®Google Scholar
• Grossman AB, Woolley-Levine S, Bradley WG, Miller RG. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:56–61.
   PubMed Web of Science ®Google Scholar
• Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2011;12:45–51.
   PubMed Web of Science ®Google Scholar
• McHutchison CA, Leighton DJ, McIntosh A, Cleary E, Warner J, Porteous M, et al. Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND. J Neurol Neurosurg Psychiatry. 2020;91:245–53.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Thomas H, Abrahams, S, et al. Screening for cognition and behaviour changes in ALS. 8421. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Foucher J, Winroth I, Lovik A, Sennfält S, Pereira JB, Fang F, et al. Validity and reliability measures of the Swedish Karolinska version of the Edinburgh cognitive and behavioral ALS screen (SK-ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2023;24(7–8):713–18.
   Web of Science ®Google Scholar
• Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 2016;87:539–47.
   PubMed Web of Science ®Google Scholar
• Canosa A, Pagani M, Cistaro A, Montuschi A, Iazzolino B, Fania P, et al. 18F-FDG-PET correlates of cognitive impairment in ALS. Neurology 2016;86:44–9.
   PubMed Web of Science ®Google Scholar
• Canosa A, Moglia C, Manera U, Vasta R, Torrieri MC, Arena V, et al. Metabolic brain changes across different levels of cognitive impairment in ALS: a 18 F-FDG-PET study. J Neurol Neurosurg Psychiatry 2021;92:357–63.
   Web of Science ®Google Scholar
• Kassubek J, Pagani M. Imaging in amyotrophic lateral sclerosis: MRI and PET. Curr Opin Neurol. 2019;32:740–6.
   PubMed Web of Science ®Google Scholar
• Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, et al. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging. 2014;41:844–52.
   PubMed Web of Science ®Google Scholar
• Pagani M, Chiò A, Valentini MC, Öberg J, Nobili F, Calvo A, et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology 2014;83:1067–74.
   PubMed Web of Science ®Google Scholar
• Matías-Guiu JA, Pytel V, Cabrera-Martín MN, Galán L, Valles-Salgado M, Guerrero A, et al. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2016;43:2050–60.
   PubMed Web of Science ®Google Scholar
• Canosa A, Calvo A, Moglia C, Manera U, Vasta R, Di Pede F, et al. Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study. Eur J Nucl Med Mol Imaging. 2021;48:1124–33.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Meles SK, Vadasz D, Renken RJ, Sittig‐Wiegand E, Mayer G, Depboylu C, et al. FDG PET, dopamine transporter SPECT, and olfaction: combining biomarkers in REM sleep behavior disorder. Movement Disorders. 2017;32:1482–6.
   PubMed Web of Science ®Google Scholar
• Peretti DE, Renken RJ, Reesink FE, de Jong BM, De Deyn PP, Dierckx RAJO, et al. Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis. Neuroimage Clin. 2021;30:102625.
   PubMed Web of Science ®Google Scholar
• Crockford CJ, Kleynhans M, Wilton E, Radakovic R, Newton J, Niven EH, et al. ECAS A-B-C: alternate forms of the Edinburgh cognitive and behavioural ALS Screen. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:57–64.
   PubMed Web of Science ®Google Scholar
• Della Rosa PA, Cerami C, Gallivanone F, Prestia A, Caroli A, Castiglioni I, et al. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics 2014;12:575–93.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2020. Vienna, Austria. Available at: https://www.r-project.org.
   Google Scholar
• De Vocht J, Van Weehaeghe D, Ombelet F, Masrori P, Lamaire N, Devrome M, et al. Differences in cerebral glucose metabolism in ALS patients with and without C9orf72 and SOD1 mutations. Cells 2023;12:933.
   PubMed Web of Science ®Google Scholar
• Van Laere K, Vanhee A, Verschueren J, De Coster L, Driesen A, Dupont P, et al. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol. 2014;71:553–61.
   PubMed Web of Science ®Google Scholar
• Van Weehaeghe D, Ceccarini J, Delva A, Robberecht W, Van Damme P, Van Laere K. Prospective validation of 18F-FDG brain PET discriminant analysis methods in the diagnosis of amyotrophic lateral sclerosis. J Nucl Med. 2016;57:1238–43. Epub 2016 Mar 3. PMID: 26940764.
   PubMed Web of Science ®Google Scholar
• Ashraf A, Fan Z, Brooks DJ, Edison P. Cortical hypermetabolism in MCI subjects: a compensatory mechanism? Eur J Nucl Med Mol Imaging. 2015;42:447–58.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu J, Wang Z, Sun P, Li K, Liang P. Dysfunctional interactions between the default mode network and the dorsal attention network in subtypes of amnestic mild cognitive impairment. Aging. 2019;11:9147–66.
   PubMedGoogle Scholar
• Turken AU, Dronkers NF. The neural architecture of the language comprehension network: converging evidence from lesion and connectivity analyses. Front Syst Neurosci. 2011;5:1.
   PubMedGoogle Scholar
• Shekari E, Nozari N. A narrative review of the anatomy and function of the white matter tracts in language production and comprehension. Front Hum Neurosci. 2023;17:1139292.
   PubMed Web of Science ®Google Scholar
• Rajagopalan V, Pioro EP. Longitudinal 18F-FDG PET and MRI reveal evolving imaging pathology that corresponds to disease progression in a patient with ALS-FTD. Front Neurol. 2019;10:234.
   PubMed Web of Science ®Google Scholar
• Canosa A, Palumbo F, Iazzolino B, Peotta L, Di Pede F, Manera U, et al. The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in amyotrophic lateral sclerosis. Neurobiol Aging. 2021;98:205–13.
   PubMed Web of Science ®Google Scholar
• Stern Y. Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol. 2012;11:1006–12.
   PubMed Web of Science ®Google Scholar
• Temp AGM, Kasper E, Machts J, Vielhaber S, Teipel S, Hermann A, et al. Cognitive reserve protects ALS-typical cognitive domains: a longitudinal study. Ann Clin Transl Neurol. 2022;9:1212–23.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
   PubMed Web of Science ®Google Scholar
• Agosta F, Canu E, Valsasina P, Riva N, Prelle A, Comi G, et al. Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34:419–27.
   PubMed Web of Science ®Google Scholar
• Trojsi F, Di Nardo F, D'Alvano G, Passaniti C, Sharbafshaaer M, Canale F, et al. Cognitive, behavioral, and brain functional connectivity correlates of fatigue in amyotrophic lateral sclerosis. Brain Behav. 2023;13:e2931.
   PubMed Web of Science ®Google Scholar